ORMP$4.112.84%-0.12
Oramed Pharmaceuticals Inc (ORMP)
Date: 2026-10-30 16:00O: 4.22H: 4.29L: 4.08C: 4.11Vol: 91.51k
Oramed Pharmaceuticals Inc stock is traded at $4.11, with a volume of 91,505. It is down -2.84% in the last 24 hours and down -11.99% over the past month. Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Previous Close:
$4.23
Open:
$4.22
24h Volume:
91,505
Relative Volume:
0.87
Market Cap:
$170.97M
Revenue:
$2.00M
Net Income/Loss:
$109.16M
P/E Ratio:
1.59
EPS:
$2.58
Net Cash Flow:
-$9.11M
1W Performance:
-0.48%
1M Performance:
-11.99%
6M Performance:
+5.93%
1Y Performance:
+71.25%
1-Day Range:
$4.08$4.29
1-Week Range:
$4.04$4.29
52-Week Range:
$2.09$5.47
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Name
Oramed Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
646-844-1164Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, USACompare ORMP vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORMP Oramed Pharmaceuticals Inc | $4.11 | $170.97M | $2.00M | $109.16M | -$9.11M | $2.58 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oramed Pharmaceuticals Inc Stock (ORMP) Insider Trading
- Avi GabayOct 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.67
- #Shares
- 20,000
- Value ($)
- 93,400
- #Shares Total
- 0
- Hexter JoshuaOct 01 '26COO & CBO
- Transaction
- Sale
- Cost
- $4.51
- #Shares
- 30,000
- Value ($)
- 135,330
- #Shares Total
- 1,328,130
- Joshua HexterOct 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.67
- #Shares
- 30,000
- Value ($)
- 140,100
- #Shares Total
- 0
- Hexter JoshuaJul 02 '26COO & CBO
- Transaction
- Option Exercise
- Cost
- $3.69
- #Shares
- 50,000
- Value ($)
- 184,500
- #Shares Total
- 1,073,384
- Hexter JoshuaJul 01 '26COO & CBO
- Transaction
- Sale
- Cost
- $4.46
- #Shares
- 137,000
- Value ($)
- 611,431
- #Shares Total
- 1,023,384
- Gabay AvrahamJul 01 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $4.51
- #Shares
- 73,360
- Value ($)
- 330,744
- #Shares Total
- 671,785
- Hexter JoshuaJul 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.81
- #Shares
- 137,000
- Value ($)
- 658,970
- #Shares Total
- 0
- Gabay AvrahamJul 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.81
- #Shares
- 93,360
- Value ($)
- 449,062
- #Shares Total
- 0
- KIDRON NADAVJan 22 '26President and CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 109,000
- Value ($)
- 0
- #Shares Total
- 3,355,238
- Gabay AvrahamJan 22 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 19,000
- Value ($)
- 0
- #Shares Total
- 649,256
